Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs

Por Giuliano, Francesco, Warner, Timothy D
Publicado em 1999

Cyclooxygenase-3 (COX-3): Filling in the gaps toward a COX continuum?

Por Warner, Timothy D., Mitchell, Jane A.
Publicado em 2002

Nonsteroidal antiinflammatory drugs inhibiting prostanoid efflux: As easy as ABC?

Por Warner, Timothy D., Mitchell, Jane A.
Publicado em 2003

Interactions between inducible isoforms of nitric oxide synthase and cyclo-oxygenase in vivo: investigations using the selective inhibitors, 1400W and celecoxib

Por Hamilton, Lorna C, Warner, Timothy D
Publicado em 1998

Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy

Por Mitchell, Jane A, Warner, Timothy D
Publicado em 1999

Reply to Ricciotti et al.: Evidence for vascular COX isoforms

Por Mitchell, Jane A., Warner, Timothy D.
Publicado em 2013

Anti-platelet drugs and their necessary interaction with endothelial mediators and platelet cyclic nucleotides for therapeutic efficacy()

Por Knowles, Rebecca B., Warner, Timothy D.
Publicado no Pharmacol Ther (2019)

Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy

Por Warner, Timothy D, Nylander, Sven, Whatling, Carl
Publicado em 2011

Expression and activation of the farnesoid X receptor in the vasculature

Por Bishop-Bailey, David, Walsh, Desmond T., Warner, Timothy D.
Publicado em 2004

A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner

Por Hamilton, Lorna C, Vojnovic, Ivana, Warner, Timothy D
Publicado em 1999

Bisphenol A diglycidyl ether (BADGE) is a PPARγ agonist in an ECV304 cell line

Por Bishop-Bailey, David, Hla, Timothy, Warner, Timothy D
Publicado em 2000

Expression of the PlA2 allele of glycoprotein IIIa and its impact on platelet function

Por Floyd, Christopher N, Ferro, Albert, Warner, Timothy D
Publicado no JRSM Cardiovasc Dis (2015)

96-well plate-based aggregometry

Por Chan, Melissa V., Armstrong, Paul C., Warner, Timothy D.
Publicado no Platelets (2018)

Relationship between endogenous colony stimulating factors and apoptosis in human colon cancer cells: role of cyclo-oxygenase inhibitors

Por Calatayud, Sara, Warner, Timothy D, Breese, Emma J, Mitchell, Jane A
Publicado em 2001

Not all light transmission aggregation assays are created equal: qualitative differences between light transmission and 96-well plate aggregometry

Por Chan, Melissa V., Leadbeater, Philip D., Watson, Steve P., Warner, Timothy D.
Publicado no Platelets (2018)

Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond)

Por Crescente, Marilena, Menke, Laura, Chan, Melissa V, Armstrong, Paul C, Warner, Timothy D
Publicado no Br J Pharmacol (2018)

Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture

Por Bishop-Bailey, David, Larkin, Simon W, Warner, Timothy D, Chen, Gong, Mitchell, Jane A
Publicado em 1997

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis

Por Warner, Timothy D., Giuliano, Francesco, Vojnovic, Ivana, Bukasa, Antoaneta, Mitchell, Jane A., Vane, John R.
Publicado em 1999

Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy

Por Hoefer, Thomas, Armstrong, Paul C., Finsterbusch, Michaela, Chan, Melissa V., Kirkby, Nicholas S., Warner, Timothy D.
Publicado no Arterioscler Thromb Vasc Biol (2015)

Histone H4 induces platelet ballooning and microparticle release during trauma hemorrhage

Por Vulliamy, Paul, Gillespie, Scarlett, Armstrong, Paul C., Allan, Harriet E., Warner, Timothy D., Brohi, Karim
Publicado no Proc Natl Acad Sci U S A (2019)